- $14.48m
- $19.60m
- $52.68m
Brief: Iridex Reports Q4 Loss Per Share $0.01
Brief: IRIDEX Announces Strategic Collaboration With Topcon Corp
Brief: Iridex Announces Preliminary Operational And Financial Results For Q4 And FY2020
Brief: Iridex Corp Says Micropulse Transscleral Laser Therapy Now Accepted In European Glaucoma Society Guidelines
Brief: IRIDEX Q3 Loss Per Share $0.12
Brief: Iridex Reports Q2 Loss Per Share Of $0.20
Brief: Iridex Says Size Of Board Was Increased From 6 To 7 Members As Of April 20 - SEC Filing
Brief: Iridex Says Appointed James Mackaness To Serve As Interim CFO
Brief: Iridex Corp Reports Quarterly Loss Per Share Of $0.11
U.S. STOCKS ON THE MOVE-JPMorgan Chase, Wells Fargo, GameStop, Tesla
U.S. STOCKS ON THE MOVE-JPMorgan Chase, Wells Fargo, GameStop, Tesla, Boston Scientific
Brief: Iridex Sees FY 2019 Revenue $43.3 Million To $43.5 Million
Brief: Iridex Corp Posts Qtrly Total Revenue Of $10.7 Million
Brief: Iridex Announces Appointment Of Robert Gunst As Chairman Of Board Of Directors
Brief: Iridex Reports Q2 2019 Results
Brief: IRIDEX Says David Bruce Appointed CEO
Brief: IRIDEX QTRLY Diluted Loss Per Share $0.22
Brief: IRIDEX Corp says Scott Shuda Appointed To Co's Board Of Directors
Brief: Ken Ludlum Appointed To Iridex Board Of Directors